• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Incyte Corp.

    6/18/25 4:01:35 PM ET
    $INCY
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $INCY alert in real time by email
    S-8 1 tm2517983d1_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on June 18, 2025.

    Registration No. 333-

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form S-8

     

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

    INCYTE CORPORATION

    (Exact name of registrant as specified in its charter)

     

    Delaware   94-3136539
    (State or other jurisdiction of   (I.R.S. Employer
    incorporation or organization)   Identification No.)
         
    1801 Augustine Cut-Off
    Wilmington, Delaware
      19803
    (Address of Principal Executive Offices)   (Zip Code)
         
    INCYTE CORPORATION AMENDED AND RESTATED
    2010 STOCK INCENTIVE PLAN
    (Full title of the plan)
         
    HERVÉ HOPPENOT   Copy to:
    President and Chief Executive Officer   STANTON D. WONG
    Incyte Corporation   Pillsbury Winthrop Shaw Pittman LLP
    1801 Augustine Cut-Off
    Wilmington, Delaware

    (302) 498-6700
      Four Embarcadero Center, 22nd Floor
    San Francisco, California 94111
    (415) 983-1000
    (Name, address and telephone number
    , including area code, of agent for service)
       

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer ” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

      

    Large accelerated filer x   Accelerated filer ¨
         
    Non-accelerated filer ¨
    (Do not check if a smaller reporting company)
      Smaller reporting company ¨
        Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

     

     

     

    PART I

     

    INFORMATION REQUIRED PURSUANT

    TO GENERAL INSTRUCTION E TO FORM S-8

     

    General Instruction E Information

     

    This registration statement (the “Registration Statement”) is being filed for the purpose of increasing the number of securities of the same class as other securities for which a Registration Statement of Incyte Corporation (the “Registrant”) on Form S-8 relating to the same employee benefit plan is effective.

     

    The Registrant’s Form S-8 Registration Statements filed with the Securities and Exchange Commission on June 15, 2010 (File No. 333-167526), June 15, 2011 (File No. 333-174918), June 19, 2012 (File No. 333-182218), June 18, 2013 (File No. 333-189424), August 6, 2014 (File No. 333-197907), June 17, 2016 (File No. 333-212104), May 24, 2018 (File No. 333-225181), April 30, 2019 (File No. 333-231129), June 11, 2021 (File No. 333-257041), and June 30, 2023 (File No. 333-273057) are hereby incorporated by reference.

     

    Part II

     

    Information Required in the Registration Statement

     

    Item 3.Incorporation of Documents by Reference.

     

    The following documents previously filed by Registrant with the Securities and Exchange Commission are hereby incorporated by reference in this Registration Statement:

     

    (1)Registrant’s Annual Report on Form 10-K for the year ended December 31, 2024;

     

    (2)Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025;

     

    (3)Registrant’s Current Reports on Form 8-K filed on January 10, 2025, May 14, 2025, and June 11, 2025; and

     

    (4)The description of the Common Stock contained in Registrant’s Registration Statement on Form 8-A filed January 5, 1996.

     

    In addition, all documents subsequently filed by Registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents. The Registrant is not, however, incorporating, in each case, any documents or information that the Registrant is deemed to furnish and not file in accordance with Securities and Exchange Commission rules.

     

    Any statement contained in this Registration Statement or in a document incorporated by reference in this Registration Statement shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in this Registration Statement or in any subsequently filed document that is deemed to be incorporated by reference in this Registration Statement modifies or supersedes such statement.

     

    Item 8.Exhibits

     

    Exhibit  
    Number Exhibit
       
    5.1 Opinion of Pillsbury Winthrop Shaw Pittman LLP.
    23.1 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.
    23.2 Consent of Pillsbury Winthrop Shaw Pittman LLP (included in Exhibit 5.1).
    24.1 Power of Attorney (included on the signature page hereto).
    107.1 Calculation of Filing Fee Tables

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8, and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Wilmington, State of Delaware, on June 18, 2025.

     

      INCYTE CORPORATION
       
       
      By /s/ Hervé Hoppenot
        Hervé Hoppenot
        President and Chief Executive Officer (Principal Executive Officer)

     

    POWER OF ATTORNEY

     

    KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Hervé Hoppenot, Christiana Stamoulis, and Sheila Denton, and each of them, his or her true and lawful attorneys-in-fact and agents, each with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, to this Registration Statement, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or her substitute or substitutes, may do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date indicated:

     

    Signature   Title   Date
    /s/ Hervé Hoppenot   President and Chief Executive Officer  
    Hervé Hoppenot   (Principal Executive Officer) and Chairman   June 18, 2025
             
    /s/ Christiana Stamoulis   Executive Vice President and Chief Financial Officer  
    Christiana Stamoulis   (Principal Financial Officer)   June 18, 2025
             
    /s/ Thomas R. Tray   Vice President and Chief Accounting Officer  
    Thomas R. Tray   (Principal Accounting Officer)   June 18, 2025
             
    /s/ Julian C. Baker   Director  
    Julian C. Baker       June 18, 2025
             
    /s/ Jean-Jacques Bienaimé   Director  
    Jean-Jacques Bienaimé       June 18, 2025
             
    /s/ Otis W. Brawley   Director  
    Otis W. Brawley       June 18, 2025
             
    /s/ Paul J. Clancy   Director  
    Paul J. Clancy       June 18, 2025
             
    /s/ Jacqualyn A. Fouse   Director  
    Jacqualyn A. Fouse       June 18, 2025
             
    /s/ Edmund P. Harrigan   Director  
    Edmund P. Harrigan       June 18, 2025
             
    /s/ Katherine A. High   Director  
    Katherine A. High       June 18, 2025
             
    /s/ Susanne Schaffert   Director  
    Susanne Schaffert       June 18, 2025

     

    2

    Get the next $INCY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $INCY

    DatePrice TargetRatingAnalyst
    6/16/2025$107.00Hold → Buy
    Stifel
    3/18/2025Buy → Neutral
    Guggenheim
    3/18/2025Outperform → Mkt Perform
    William Blair
    12/17/2024$77.00Neutral
    UBS
    10/29/2024$68.00 → $90.00Neutral → Buy
    BofA Securities
    10/1/2024$84.00Outperform
    Wolfe Research
    9/18/2024$83.00 → $74.00Buy → Hold
    Truist
    7/2/2024$52.00 → $48.00Market Perform → Underperform
    BMO Capital Markets
    More analyst ratings